INS and sensorineural hearing loss disorder: Clinical screening protocols for MDM are usually based on typical clinical phenotypes, including maternally inherited, the need for insulin therapy due to progressive pancreas β cell dysfunction, neurosensory deafness, and elevated serum lactate levels.